Haier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution Partner

Haier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution Partner

Driving Digital Transformation in Blood Management for Plasma Collection Centers, Hospitals, and Blood Bank Centers KUALA LUMPUR, Malaysia, July 21, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) participated at the ISBT Congress 2026 in Kuala...

The HKIC Presents Stellar Annual Report and Joins Hands with Beyond Ventures to Support World-Class Ophthalmic Healthcare Flagship Projects

The HKIC Presents Stellar Annual Report and Joins Hands with Beyond Ventures to Support World-Class Ophthalmic Healthcare Flagship Projects

"Patient Capital" Nurtures Life Science Innovations: MingMed and Super Vision Featured as Selected Investment Stories in the HKIC's Annual Report HONG KONG, July 17, 2026 /PRNewswire/ -- Beyond Ventures, a Hong Kong-based venture capital firm,...

Coremail Presents AI-Native Secure Email System at LEAP East 2026

Coremail Presents AI-Native Secure Email System at LEAP East 2026

HONG KONG, July 16, 2026 /PRNewswire/ -- From July 8 to 10, 2026, Coremail participated in the Asia LEAP East International Technology and Information Technology Exhibition 2026 held in Hong Kong, showcasing its Coremail AI-Native Secure Email...

Merz Aesthetics Presents Ultherapy Mask - PDRN Peptide Radiance and Launches its 2026 Campaign at the Ultherapy PRIME Soirée in Malaysia

Merz Aesthetics Presents Ultherapy Mask - PDRN Peptide Radiance and Launches its 2026 Campaign at the Ultherapy PRIME Soirée in Malaysia

Merz Aesthetics introduces its 2026 campaign "See My Skin, Lift My Way", celebrating individuality, authenticity and the belief that every skin journey is unique, during an event in Malaysia Media, key opinion leaders and aesthetic physicians from...

From "Traveling with Children" to "A Vacation for the Whole Family": The Sanya EDITION Redefines Family Travel Experiences

From "Traveling with Children" to "A Vacation for the Whole Family": The Sanya EDITION Redefines Family Travel Experiences

SANYA, China, June 30, 2026 /PRNewswire/ -- As family travel continues to evolve, the concept of a family vacation is shifting from simply traveling with children to creating meaningful experiences for every family member. Today's families...

Hoymiles Presents Full-Scenario Energy Solutions and Expands Strategic Partnerships at Intersolar Europe 2026

Hoymiles Presents Full-Scenario Energy Solutions and Expands Strategic Partnerships at Intersolar Europe 2026

MUNICH, June 26, 2026 /PRNewswire/ -- Hoymiles, a global leader in smart energy solutions, presented its comprehensive open-energy ecosystem at Intersolar Europe 2026. Building on its world-renowned microinverter expertise, the company officially...

Mabwell Presents Clinical Results of Nectin-4-Targeting ADC 9MW2821 at 2026 ESMO Gynaecological Cancers Congress

Mabwell Presents Clinical Results of Nectin-4-Targeting ADC 9MW2821 at 2026 ESMO Gynaecological Cancers Congress

SHANGHAI, June 18, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, presented two latest clinical study results of its independently developed...

Shanghai Electric Presents Full-Chain Collaborative Solutions for Zero-Carbon Transition at Carbon Neutrality Expo 2026

Shanghai Electric Presents Full-Chain Collaborative Solutions for Zero-Carbon Transition at Carbon Neutrality Expo 2026

SHANGHAI, June 16, 2026 /PRNewswire/ -- Shanghai Electric ("the Company") (SEHK: 02727, SSE: 601727) has successfully concluded its exhibition at the 2026 Shanghai International Carbon Neutrality Expo in Technologies, Products and Achievements...

Minghui Pharmaceutical Presents Compelling Phase I/II Results for MHB018A, a Novel Subcutaneous Anti-IGF-1R Antibody for Thyroid Eye Disease, in an Oral Presentation at ENDO 2026, the Endocrine Society's Annual Meeting

Minghui Pharmaceutical Presents Compelling Phase I/II Results for MHB018A, a Novel Subcutaneous Anti-IGF-1R Antibody for Thyroid Eye Disease, in an Oral Presentation at ENDO 2026, the Endocrine Society's Annual Meeting

MHB018A demonstrated outstanding clinical activity in both active and chronic thyroid eye disease At 450 mg Q4W, MHB018A achieved a remarkable 81% proptosis response at Week 12 in active TED and a 76% proptosis response at Week 24 in chronic TED...

Bambusa Therapeutics Presents Positive Preliminary Multiple Ascending Dose Phase 1 Data for BBT002 at the European Academy of Allergy & Clinical Immunology (EAACI) Annual Congress 2026

Bambusa Therapeutics Presents Positive Preliminary Multiple Ascending Dose Phase 1 Data for BBT002 at the European Academy of Allergy & Clinical Immunology (EAACI) Annual Congress 2026

- BBT002 is a next-generation, long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-5 - - BBT002 demonstrated rapid, deep, and sustained biomarker effects through at least 8 weeks following...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • menu
    menu